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Abstract: The in vitro biocompatibility of Graphene Oxide (GO) nanosheets, which were obtained
by the electrochemical exfoliation of graphite electrodes in an electrolytic bath containing salts, was
compared with the pristine Single Wall Carbon Nanotubes (p-SWCNTs) under the same experimental
conditions in different human cell lines. The cells were treated with different concentrations of
GO and SWCNTs for up to 48 h. GO did not induce any significant morphological or functional
modifications (demonstrating a high biocompatibility), while SWNCTs were toxic at any concentration
used after a few hours of treatment. The cell viability or cytotoxicity were detected by the trypan blue
assay and the lactate dehydrogenase LDH quantitative enzymatic test. The Confocal Laser Scanning
Microscopy (CLSM) and transmission electron microscopy (TEM) analysis demonstrated the uptake
and internalization of GO sheets into cells, which was localized mainly in the cytoplasm. Different
results were observed in the same cell lines treated with p-SWCNTs. TEM and CLSM (Confocal
Laser Scanning Microscopy) showed that the p-SWCNTs induced vacuolization in the cytoplasm,
disruption of cellular architecture and damage to the nuclei. The most important result of this study
is our finding of a higher GO biocompatibility compared to the p-SWCNTs in the same cell lines. This
means that GO nanosheets, which are obtained by the electrochemical exfoliation of a graphite-based
electrode (carried out in saline solutions or other physiological working media) could represent an
eligible nanocarrier for drug delivery, gene transfection and molecular cell imaging tests.
Keywords: p-SWCNTs; graphene oxide; biocompatibility; cytotoxicity; LDH
1. Introduction
In recent years, scientific communities have devoted a considerable effort to evaluate the
biocompatibility of nanomaterials with the aim of ensuring their safe use in the emerging fields
of nanomedicine and nano-pharmacology [1,2]. Graphene (G) represents a promising nanomaterial for
several biomedical applications due to its unique atomic structure that allows its functionalization, low
cytotoxic profile in biosystems [3] and high surface area-to-volume ratio. This ensures a relevant
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loading capacity of the bioactive molecules, genes and miRNA for drug/miRNA delivery and
gene transfection purposes [4,5]. Furthermore, the surface chemistry of graphene-based materials,
which is strictly related to their functionalization degree and composition [6,7], can be specifically
modulated to enhance exceptional optical and electrical properties in G that are useful for in vitro
cell imaging and in vivo monitoring of these nanomaterials during experimentations [8–10]. For this
purpose, G derivatives, such as Graphene Oxides (GO), Reduced Graphene (RG) and Graphene
NanoComposites (GNCs), have been widely investigated in terms of pharmacokinetics, toxicity and
cytocompatibility [11–13]. Currently, pristine Single Wall Carbon Nanotubes (p-SWCNTs) are widely
studied for their effects on cells, animals and environment in addition to being evaluated for their
biosafety [14–16]. Many studies on p-SWCNTs show that they exhibit higher in vitro and in vivo
toxicity in biological systems compared with other G derivatives, because their fiber shape can cause
cellular damages. Furthermore, the carbon nanotubes contain contaminants, such as heavy metals
(employed as catalysts for their assembly), and their diameter represents a crucial structural aspect as
it affects functionalization [17]. It has been previously reported that the biocompatibility of p-SWCNTs
improved after binding with bio-polymers [18]. Although our previous work [19] demonstrated
that functionalized (i.e., oxidized SWCNTs) nanotubes exhibit certain levels of toxicity in embryos,
we compared the biocompatibility of p-SWCNTs with GO nanosheets in different human cell lines in
this present study.
Regarding the GO biosafety, many recent studies have demonstrated its biocompatibility in
cells or living biosystems [20–22]. These promising effects could be partially explained by the
metal-free composition of GO and its geometrical structure, which are namely sheets and not nanotubes.
Currently, the most representative studies focus on the application of GO in the Henrietta Lacks cells
(HeLa) derived from cervical cancer tissue and Human Umbilical Vein Endothelial cells (HUVEC),
which are both selected as the models of stable epithelial and endothelial cell lines, respectively.
Furthermore, GO has been also applied in the Human Dermal Fibroblast (HDF) and NIH 3T3
(RRID:CVCL_0594) murine fibroblast cells [23]. Experimental evidence shows that GO exhibits
dose-dependent toxicity in both human and mice [24,25] cells. This aspect is of crucial importance
when nanomaterials are used for drug delivery applications, gene transfection and other biomedical
purposes. In this regard, we are reporting on the cytotoxicity effects of GO and p-SWCNTs on different
cell lines (the human endothelial-like immortalized cell line EaHy926 derived from fusion of HUVEC
cells with the bronchial carcinoma cell line-A549, the human laryngeal epidermoid carcinoma HEp-2
cells, HUVEC and HeLa) in this present work by exploring the cell viability in the presence of GO and
p-SWCNTs, especially in terms of exposure times and concentration of these nanomaterials. Cellular
uptake, distribution and morphological changes induced by GO and p-SWCNTs into the cells were
monitored by Confocal Laser Scanning Microscopy (CLSM).
2. Results
2.1. Nanomaterials Characterization
Figure 1 shows the Atomic Force Microscopy (AFM), Raman spectrum and X-ray Photoelectron
Spectroscopy (XPS) of GO nanosheets. A complete chemical–physical characterization of GO is
summarized in Tables 1 and 2. Figure 1A shows the AFM of GO organized in 2 layers. The Raman
spectrum (Figure 1B) shows GO defects (D peak) in the 2 layers (G′). The defects shown in the Raman
spectrum are better defined in Figure 1C and in Table 2, where the XPS reveals and quantifies carboxylic,
carbonyl, ether and alcoholic groups. Furthermore, the thermal analysis and acidic sites determination
assays revealed that the GO surfaces and sides have a low number of oxidized functional groups [26].
The thickness, surface area and number of layers were estimated by AFM analysis and are reported in
Table 1. The elemental compositional analysis revealed the complete absence of metals, confirming the
“metal-free” nature of these GO derivatives.
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The chemical–physical properties of p-SWCNTs are reported in Table 3. The elemental analysis
revealed the presence of Si, S, Fe, Ca, Cr and Co as the main impurities, which are used as catalysts for
the growth of p-SWCNTs. Considering that the metallic elements could be responsible for cytotoxicity
(and for this reason, a soft physical purification procedure has been applied in order to minimize the
metal content in nanotubes), the concentration of metals in p-SWCNTs was quantified by using the
ICP-OES (Inductively Coupled Plasma Optical Emission Spectrometry) analytical method. Among
the possible contaminants, only cobalt was found at a final concentration of 30 µM. The oxygenated
functionalities on walls, sides and surfaces in the p-SWCNTs could be related to the air annealing
purification treatment. p-SWCNTs were further cut with various cycles of sonication (see Section 4)
which leads to a reduction of approximately 30% in length.
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Table 1. Physico-chemical properties of GO.
Chemical Properties Metallic Elements
Elemental analysis a
(% w/w)
Si (n.d)
S (n.d)
Ca (n.d.)
Cr (n.d.)
Fe (n.d.)
Co (n.d.)
Physical Properties Range Values
Surface Area (µm2) b 0.1–3.0
Thickness (nm) b 1.2 ± 0.3
Number of Layer b 2 (bilayer)
Weight loss % (TGA) c 0.42 ± 0.40
Acidic sites (nmol/mg) d 4.02 ± 0.23
Extent of defects (ID/IG) e 0.10
a Evaluated by XRF spectroscopy (mean ± SE). b Evaluated by AFM analysis, where the average size of GO
sheets was obtained by measuring a significant number of samples (average was calculated using 80 sheets per
GO). c Mean ± SD. d Acidic sites evaluated as described in reference [25] (mean ± SD). e Evaluated by Raman
spectroscopy. n.d.: not detectable.
Table 2. Binding Energies (BE/eV) and deconvoluted peaks (%) for C1s of GO.
Peak BE (eV) C1s At. % Functional Groups
284.4 59.0 C-C
285.4 16.0 C-OH
286.6 14.0 C-O
287.7 7.0 C=O
289.0 4.0 C(O)O
290.7 2.2 pi–pi *
pi * refers to antibonding pimolecular orbitals, with the highest energy level.
Table 3. Physico-chemical properties of p-SWCNTs.
Chemical Properties Metallic Elements
Elemental analysis a
(% w/w)
Si 0.20 ± 0.06
S 0.47 ± 0.04
Ca 1.14 ± 0.31
Cr 1.03 ± 0.15
Fe 1.00 ± 0.25
Co 3.57 ± 0.56
Physical Properties Range Values
Diameter (nm) b 2.35 ± 0.40
Length (µm) b 0.82 ± 0.42
Weight loss % (TGA) c 0.50 ±0.50
Acidic sites (nmol/mg) d 24.25 ± 1.10
Extent of defects (ID/IG) e 0.94
a Evaluated by XRF spectroscopy (mean ± SE). b Evaluated by TEM analysis (mean ± SD). c Mean ± SD. d Acidic
sites evaluated as described in reference [26] (mean ± SD). e Evaluated by Raman spectroscopy.
2.2. Effects of GO and p-SWCNTs Treatments on Cell Lines
The cytotoxicity of p-SWCNTs and GO at 0.2 µg/mL and 2 µg/mL was measured by quantifying
the release of lactate dehydrogenase (LDH) in the different cell lines and by the trypan blue exclusion
test (shown in Tables 4 and 5).
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Table 4. Viability test for different type of cells.
A. EaHy926
Time (h) CTRL p-SWCNTs0.2 µg/mL
p-SWCNTs
2 µg/mL
GO
0.2 µg/mL
GO
2 µg/mL
6 99.40 94.40 84.32 95.50 95.20
12 98.20 80.20 78.20 92.60 91.60
24 98.20 70.20 62.50 92.60 89.40
48 98.20 56.60 47.30 92.00 88.60
B. HEp-2
Time (h) CTRL p-SWCNTs0.2 µg/mL
p-SWCNTs
2 µg/mL
GO
0.2 µg/mL
GO
2 µg/mL
6 98.60 90.30 77.30 94.50 93.80
12 97.80 80.00 62.20 89.80 86.00
24 96.00 69.00 58.00 87.00 82.00
48 91.20 64.20 45.30 81.40 80.00
C. HUVEC
Time (h) CTRL p-SWCNTs0.2 µg/mL
p-SWCNTs
2 µg/mL
GO
0.2 µg/mL
GO
2 µg/mL
6 98.30 92.40 82.40 98.00 97.50
12 97.60 85.60 70.70 97.80 96.20
24 98.20 72.20 62.80 96.70 95.70
48 97.30 66.00 58.20 96.50 94.20
D. HeLa
Time (h) CTRL p-SWCNTs0.2 µg/mL
p-SWCNTs
2 µg/mL
GO
0.2 µg/mL
GO
2 µg/mL
6 97.20 85.70 84.60 96.30 95.20
12 98.50 75.30 73.90 96.60 94.20
24 97.60 72.20 65.00 95.40 91.60
48 96.70 67.00 65.00 93.20 89.20
% of viable cells determined by Trypan blue exclusion test, as described in Materials and Methods. The values
represent the mean obtained in 3 experiments. SD were between ±1% and ±2%.
Table 5. LDH activity and % of cytotoxicity.
A. EaHy926
Time (h) CTRL p-SWCNTs0.2 µg/mL
p-SWCNTs
2 µg/mL
GO
0.2 µg/mL
GO
2 µg/mL
12 0.16 0.28 (12%) 0.32 (15.4%) 0.18 (1.9%) 0.23 (6.7%)
24 0.18 0.42 (23.5%) 0.52 (33.3%) 0.22 (3.9%) 0.28 (9.8%)
48 0.25 0.54 (30.5%) 0.66 (43%) 0.36 (11.6%) 0.40 (15.8%)
B. HEp-2
Time (h) CTRL p-SWCNTs0.2 µg/mL
p-SWCNTs
2 µg/mL
GO
0.2 µg/mL
GO
2 µg/mL
12 0.18 0.38 (16.6%) 0.42 (23.5%) 0.19 (1.0%) 0.25 (6.8%)
24 0.21 0.41 (20.2%) 0.50 (29.3%) 0.24 (2.9%) 0.27 (6%)
48 0.26 0.46 (21.3%) 1.22 (102%) 0.29(3.2%) 0.35 (9%)
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Table 5. Cont.
C. HeLa
Time (h) CTRL p-SWCNTs0.2 µg/mL
p-SWCNTs
2 µg/mL
GO
0.2 µg/mL
GO
2 µg/mL
12 0.14 0.18 (1.9%) 0.30 (15%) 0.14 (0%) 0.15 (0.94%)
24 0.15 0.28 (13.2%) 0.31 (16%) 0.16 (0.9%) 0.22 (6.6%)
48 0.16 0.49 (31.7%) 0.59 (41.3%) 0.18 (1.9%) 0.28 (11.5%)
D. HUVEC
Time (h) CTRL p-SWCNTs0.2 µg/mL
p-SWCNTs
2 µg/mL
GO
0.2 µg/mL
GO
2 µg/mL
12 0.12 0.31 (17.6%) 0.45 (30.6%) 0.13 (0.9%) 0.22 (9.3%)
24 0.14 0.34 (18.9%) 0.50 (33.9%) 0,.15 (0.9%) 0.26 (11.3%)
48 0.15 0.43 (26.6%) 0.80 (61.9%) 0.17 (1.9%) 0.31 (15.4%)
LDH activity was determined in the different cell lines, as described in Materials and Methods. LDH values are
expressed as the difference between readings at 490 and 680 nm (A 490–680 nm). The % of cytotoxicity shown after
each treatment (%) was determined by applying the formula reported in Materials and Methods. The determinations
were performed 3 times and each reported value represents the mean. The SDs were between ±0.09 and ±0.2.
The cell viability (Table 4 A–D) was compromised by the addition of p-SWCNTs in all cell lines,
which was started from 12 h of exposure at the lowest concentration (0.2 µg/mL). The increase in
cell death and LDH release was time- and concentration-dependent and it differed slightly in various
cell lines. The differences were due to the size of cells and rate of mitosis. The addition of low doses
(0.2 µg/mL) of GO to cell cultures did not show cytotoxic activity in any cell line and 2 µg/mL of GO
started to induce a moderate rate of cell death only in HEp-2 cells. The time of exposure has been
shown to be an important factor for cell death and LDH release. The release of LDH and the percentage
of cytotoxicity, which are reported in Table 5 A–D, increased slightly with longer exposure times to
GO in the different cell lines but it never reached the same levels as those in the cells treated with
p-SWCNTs. Figures 2 and 3 show cytotoxicity in the cell lines after 24 h of treatment with p-SWCNTs
and GO, respectively. In Figure 2, LDH release is inversely proportional to the cell viability and
differences between controls (untreated cells), with 2 µg of p-SWCNTs for 24 h resulting in the highly
significant release of LDH in all cell lines. Figure 3 shows that in the cells treated with GO for 24 h,
the cell viability decreased significantly (p = 0.03) only in HEp-2 cells treated with 2 µg GO, while LDH
release did not change significantly. The time- (up to 72 h) and concentration-dependent (5, 10 and
20 µg/mL) curves obtained in preliminary experiments with both nanomaterials showed that higher
concentrations and longer times of exposure caused higher degrees of cell death and LDH release.Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  7 of 16 
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HUVEC and HeLa cells. The viability detected with trypan blue exclusion test was correlated to LDH
cytotoxicity. HEp-2 (2 µg/mL vs. control) p = 0.002 (LDH and Trypan blue); HUVEC (2 µg/mL vs.
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Figure 3. Effect of GO at different concentrations (0.2 and 2 µg/ L) for 24 h on Ep-2, Ea y926,
EC and eLa cells. Viability detected with Trypan blue exclusion test was correlated to LDH
(2 µg/mL GO vs. control HEp-2 p = 0.04).
2.3. Morphological Changes in Cell Lines Treated with GO Nanosheets and p-SWCNTs
The exposure of cells to 2 µg/mL of GO and 2 µg/mL of p-SWCNTs for 24 h led to a clearly visible
internalization of these nanomaterials, which appeared to be similar to intracytoplasmic electron dense
aggregates (GO) or tubular structures (p-SWCNTs) (Figures 4 and 5, respectively). The vacuolization
of cytoplasm was more evident when the cells were treated with p-SWCNTs than when treated with
GO. In some cases, nanoparticles were found inside vacuoles (Figure 5).
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Figure 5. TEM images of p-SWCNTs-treated HeLa cells. (A,B) HeLa cells controls (untreated) during
mitosis (arrowhead). (C,D) HeLa cells treated with 2 µg/mL of p-SWCNTs for 24 h were able to
incorporate p-SWCNTs (circled area, electron dense tubular structure), which are also present in the
extracellular space (arrow). Representative experiment.
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Confocal light scanning microscopy (CLSM) was used to study the morphological features seen
in p-SWCNTs and GO treated-EaHy926 cells compared with control cells. Figure 6 shows the EaHy926
control cells (Figure 6A) and EaHy926 (Figure 6B) treated with 2 µg/mL of p-SWCNTs for 24 h.
The cellular and nuclear damage (black spots) shown in Figure 6B were observed in the cells treated
with p-SWCNTs at the lowest concentration. When the spectra signals are recorded in reflectance
mode [27] (Figure 6C), the p-SWCNTs aggregates are seen as green spots in damaged nuclear areas.
The switching from black into green spots in DAPI-stained nuclei depends on the accumulation and
aggregation of p-SWCNTs and is a direct proof of damage, according to other authors [28].
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(see Materials and Methods); (B) EaHy926 treated with 2 µg/mL of p-SWCNTs for 24 h (arrows on
nuclear damage); and (C) p-SWCNTs in green. Representative experiment.
When GO was added to cell cultures under the same experimental conditions, the nuclei were not
destroyed (Figure 7A,B and supplementary Figures S1–S3). The low green signal in cytoplasm is due
to the GO nanosheets in the cytoplasm and no green signal is visible in the nuclei. All cell lines have
been treated with the described amounts of both nanomaterials, while TEM or confocal microscopy
have been performed in the samples from each cell line. The pictures shown in figures have been
chosen as the examples of the most significant experiments.Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  10 of 16 
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3. Discussion 
The present work demonstrated that the interactions of nanomaterials with human cell lines are 
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3. Discussion
The present work demonstrated that the interactions of nanomateri ls with human cell lines are
affected by their size and chemical composition, while these interactions also depend on cell types.
Regarding the composition of nanomaterials, the concern of researchers is that the substances that
are used as precursors may be toxic for operators and for human cells when they are eventually
administered as drug carriers.
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The p-SWCNTs are obtained by chemical vapor deposition (CVD) using metals as catalysts, [29]
while the PAHs (Polycyclic Aromatic Hydrocarbons) represent chemical residues that are adsorbed in
the final SWCNT products [30]. Both compounds are a risk for workers because they produce airborne
particulate matter. In order to monitor the actual risk related to the described inhaled substances in
workplaces, various techniques may be applied [31].
In the present work, the p-SWCNTs were more cytotoxic than GO in the studied cell lines, which
was demonstrated by the higher release of LDH and cell viability.
The GO nanosheets were obtained by the electrochemical exfoliation of solid Highly Oriented
Pyrolytic Graphite (HOPG) rods, which resulted in highly purified GO. This newly synthesized GO
does not contain or release metals or other substances in an aqueous solution, which was demonstrated
by XRF spectroscopy and summarized in Table 1. When comparing the elemental analysis of the latter
with that of p-SWCNTs, a substantial difference was found (Table 2). The presence of metal ions in
nanomaterials is of concern as they may induce the production of ROS (Radical Oxygenated Species)
in cells, may accumulate in macrophages and may contaminate the environment.
The oxygenated functionalities (i.e., the COOH groups) have been also detected by recording
the negative z-potential values, according to the presence of the carboxylate anions, at physiological
pH. In particular, the zeta potential value of −7.4 mV in the p-SWCNTs implies that it binds with
strong cationic substances. In contrast, the lower value of −1.4 mV detected for GO suggests the
pi–pi hydrophobic weak bonds are the most probable group that interacts with other chemical species
present in the same solutions. These carboxylic groups could be used for further functionalization as
they can be suited for binding various biological active molecules and for assembling new tools for
drug delivery into cells.
Confocal Laser Scanning Microscopy (CLSM) and TEM (Transmission Electron Microscopy)
showed that the particles of both p-SWCNTs and GO nanosheets were located inside cells so the uptake
of the nanomaterials used here was not a problem for single cells in our experimental conditions.
In our previous work [32], we showed that GO nanoribbons had low toxicity in neuroblastoma cell
lines, although we believe that the uptake of nanomaterials should be studied more extensively in
tissues and in tridimensional models.
The p-SWCNTs and GO nanosheets were internalized within 24 h in different cell lines
representing different tissues (HUVEC, EaHy926, HEp-2, HeLa). The variable values related to
cytotoxicity shown in the different cell lines should be related to the different origin, growth rate
and different activation of death modalities of cells. It has been reported [33] that the differentiated
cells undergo necrosis when their membranes are damaged, while cancerous or fibroblast-like cells
undergo apoptosis.
The evaluation of the plasma membrane integrity by trypan blue exclusion test and the release of
LDH has shown high viability levels in all cell lines after treatment with GO nanosheets at 0.2 µg/mL.
GO nanoribbons obtained from the chemical exfoliation of p-SWCNTs induced autophagy, which
was caused by ROS induction in neuroblastoma cell lines. Instead, we have shown in this study
that the GO nanosheets at low concentrations do not induce significant LDH release in various cell
lines. The cytotoxic effects induced by p-SWCNTs were clear in all cell lines. In particular, apart from
damaging cell membranes and inducing LDH release, the confocal microscopy showed nuclear damage.
The shape of nanomaterials has been shown to play an important role in cytotoxicity as the nanotubes
with their needle-like shape are similar to the asbestos fibers that can induce mesothelioma [34].
However, this concern has been adjusted as carbon nanotubes have not been shown to persist in
organisms for as long as asbestos and they do not probably get to pleura by inhalation. Furthermore,
it has not been demonstrated that the carbon nanotubes chronically activate macrophages and form
granulomas. However, the size and shape of nanomaterials remain an important issue for biosafety.
The GO nanosheets obtained in our laboratory are a promising nanomaterial to be functionalized and
used as a drug carrier because they show low cytotoxicity in different cell lines and a homogeneous
uptake in the reported cell lines. In conclusion, the results obtained here showed that GO synthesized
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by the water electrolytic oxidation of HOPG electrode might be considered a green synthesis approach
as airborne particulate matter is not produced, while no strong oxidizing acids or other toxic chemicals
are used [35]. However, more studies, including continuous monitoring in laboratories where these
nanoproducts are produced and handled, are needed in order to reduce the health risks for workers
handling nanoparticles and increase their biosafety.
4. Materials and Methods
4.1. Materials and Chemical Reagents
The p-SWCNTs were purchased from the Carbolex (Sigma Aldrich, Milan, Italy). GO was
synthesized by the electrochemical exfoliation of HOPG (Highly Oriented Pyrolytic Graphite) working
electrodes (HOPG rod electrodes were purchased from Good Fellow, TX, USA) according to the
Patent (N◦ 102015000023739). The 2-(4-Amidinophenyl)-6-indolecarbamidine dihydrochloride (DAPI)
was used for the nuclei staining in CLSM measurements, which was purchased from Sigma-Aldrich.
All chemical reagents were purchased from Sigma Aldrich and used without further purification,
unless otherwise specified. Ultra-pure water was produced by a Milli-Q system (Millipore, Billerica,
MA, USA) and used for all chemical procedures.
4.2. Determination of Metal Content of Nanotube Samples
The metal quantification of the p-SWCNTs used in the present work was determined by using
the ICP-OES apparatus (PE Sciex Elan 6000, Perkin Elmer, Norwalk, CT, USA). This quantitative
measurement was carried out in 1 mL of the working medium supernatant, in which the p-SWCNTs
were maintained in suspension for 10 days.
4.3. Air Oxidation of p-SWCNTs
Following one of the purification methodologies [36], 100 mg of carbon nanotubes was oxidized at
400 ◦C using an air flow of 12 mL/min (quartz tubular reactor of 14-mm diameter) for 1 h. To minimize
the amount of metal oxide catalysts, the oxidized carbon nanotubes (by the physical air annealing
procedures) were dispersed in 60 mL of 6 M HCl for 4 h, which involved using an ultrasonic bath.
After this, they were filtered and washed until the pH of the solution was neutral. Finally, they were
dried in the oven at 70 ◦C.
4.4. Synthesis and Characterization of GO Sheets
The GO sheets were obtained using electrochemical exfoliation/intercalation procedure from
Highly Oriented Pyrolytic Graphite (HOPG rod electrodes, from Good Fellow, TX, USA), which was
the solid precursor. The electrochemical exfoliation occurred in an electrolysis cell, where the Working
Electrode (WE) was HOPG (ϕ = 3 mm) and the reference secondary electrode was a platinum rod
(Pt; ϕ = 3 mm). These two electrodes were located at a distance of 5 cm in the electrolysis cell. A 0.1 M
LiCl aqueous working medium was employed with a 12-V potential for 1 h. A step-by-step procedure
for the electrochemical oxidative exfoliation of HOPG electrode is reported in the patent obtained in
our laboratory in 2015 Patent (N◦ 102015000023739). The final GO product is used in liquid phase and
directly collected from the electrolytic synthetic bath. An aliquot of 2 mL of the buffer with exfoliated
GO (collected directly from the electrolysis cell) was diluted to 1:10,000 in PBS in order to obtain a final
concentration of 1 mg/mL (as determined by using the conventional Faraday laws).
Raman study. The Raman spectra were collected both on a GO powder sample and on p-SWCNTs
powder deposited on a Si (111) wafer at room temperature in the back-scattering geometry with a
Renishaw spectrometer equipped with an air-cooled CCD detector and edge filters. A 488.0-nm
emission line from an Ar+ ion laser was focused on the sample by a Leica DLML microscope using
5× or 20× objectives. After this, 10-s or 20-s accumulations were generally attained for each sample
with an incident beam power of about 5 mW. The spectral resolution was 2 cm−1 and the spectra
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were calibrated using the 520.5 cm−1 line of a silicon wafer. The data analysis included the baseline
removal and curve fitting using a Lorentzian function by Peakfit 4.12 software (Jandel, AISN Software,
Erkrath, Germany).
Infrared Spectroscopy (IR) study. The IR spectra were recorded on a Perkin-Elmer Spectrum
One FT-IR spectrometer. The samples were prepared in KBr pellets.
Z-potential measurements. The Z-potential measurements were obtained by using a Zetasizer
Nano ZS equipment (Malvern, UK). This apparatus is equipped with a back-scattering detection
mode (with an angle of 173◦) and a He-Ne laser, which had a wavelength of 633 nm (Laser Doppler
Velocimetry, Malvern, UK).
Thermogravimetric Analysis (TGA). The Thermal Analysis was performed by using a
TGA/DSC1 Star System (Mettler Toledo) in N2 with a heating rate of 5 ◦C/min.
Atomic Force Microscopy (AFM). The AFM measurements were performed in air using a Veeco
Multiprobe IIIa instrument (Veeco, Santa Barbara, CA, USA). The GO was deposited using an aqueous
solution on the Mica substrates. The experiments were carried out at room temperature (20 ◦C) in
tapping mode using Si tips with a spring constant of about 40 N/m and a typical curvature radius on
the tip of 7 nm.
X-ray Photoelectron Spectroscopy (XPS). The XPS measurements were carried out using
an Omicron DAR 400 Al/Mg Kα non-monochromatic X-ray source and a VG-CLAM2 electron
spectrometer. GO (1 mg/mL) was very-well dispersed in ethanol using an ultrasonic probe and
then deposited on the silicon wafer.
4.5. Cell Lines
Different cell lines were used: Human Umbilical Vein Endothelial Cells (HUVEC) (ATCC,
Manassas, VA, USA, CRL 1730); human cervix adenocarcinoma (HeLa) (DSMZ, ACC.57); EaHy926,
an immortalized hybrid cell line derived from the fusion of HUVEC with lung carcinoma (A549) (ATCC,
Manassas, VA, USA, CRL 2922); and human laryngeal epidermoid carcinoma (HEp-2), purchased
from a Korean Cell Line Bank (KCLB No. 10023). HUVEC were cultured in EGM-2 BulletKit (CC-3162,
Lonza, Basel, Switzerland). The other cell lines were cultured in Dulbecco's modified Eagle's media
(DMEM), which was supplemented with 10% fetal bovine serum (FBS), 1% streptomycin-penicillin
and 1% L-glutamine (Gibco, Thermo Fisher Scientific, Cambridge, MA, USA).
The cells were maintained as adherent cultures in Gibco tissue culture flasks under humidified
atmosphere in 5% CO2 at 37 ◦C. The experiments were performed on cells that had grown up to
60–70% confluency.
The GO and p-SWCNTs suspensions were dispersed in distilled H2O at a concentration of
1 mg/mL and sonicated for 2 h in a 4.25 L bath type ultrasonic unit (Bransonic 220, Branson, MO, USA).
Following sonication, the suspensions were centrifuged at 13,000 rpm for 30 min and the supernatants
were transferred to fresh tubes. Both p-SWCNTs and GO were sonicated for another hour, before a
single amount was very well-dispersed in the tissue culture medium (at the desired concentration).
This single amount was ready to be used for cell treatment experiments.
Transmission electron microscopy (TEM). Cells (treated or not with GO or p-SWCNTS) were
fixed in 1% OsO4 for 2 h and progressively dehydrated by ethanol/water to an absolute ethanol series.
They were treated with propylene oxide before being embedded in EPON 812. Ultrathin sections
were counterstained with uranyl acetate and lead citrate before being studied with a Hitachi 7100
transmission electron microscope (Hitachi, Tokyo, Japan).
Confocal Laser Scanning Microscopy (CLSM). A Laser Scanning Confocal Microscope (Olympus
FV1000, Olympus, Hamburg, Germany) was used for the multi-channel imaging studies. The optical
glass slides (0.17 mm of thickness), suitable for the CLSM measurements, were sterilized and placed
in the wells of a cell culture plate, before the cells were seeded at a concentration of 105/mL.
The p-SWCNTs and GO dispersions were added to the culture medium at the concentrations and
times indicated in the Results section. At the end of incubation time, the cells were washed with
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PBS and fixed with 4% paraformaldehyde for 20 min. After washes, cells were treated with 0.1 M
glycine in PBS for 10 min and then permeabilized with 0.1% Triton in PBS solution for 5 min. After
washing, the nuclei were stained with DAPI for 5 min and then mounted with a cover slip and a drop
of mounting solution (glycerol:PBS, 3:2). The readings were carried out with a confocal microscope
(Zeiss LSM-510, Oberckoken, Germany). The laser sources were a diode at 405 nm for the blue channel
and Argon at 488 nm for the green channel. The green signal from the p-SWCNTs and GO aggregates
(488 nm for excitation and 510 nm for emission) was recorded in the cells treated with nanoparticles at
different times of incubation [37].
Trypan blue assay. The cell number and cell viability were determined by using the Trypan blue
exclusion test. Cells in the exponential phase of growth (1 × 105/mL) were seeded into a 6-well
microplate and incubated for 6, 12, 24 and 48 h with 0.2 µg/mL or 2 µg/mL of p-SWCNTs and
GO, respectively. The untreated cells were used as negative controls. The p-SWCNTs and GO stock
solutions (1 mg/mL in PBS) were sonicated for 2–4 h (4 ◦C), before being diluted in sterile culture
medium and added to the cell cultures. At the end of incubation time, cells were mechanically
scraped off, resuspended in fresh medium and incubated for 30 min with gentle shaking at 37 ◦C in an
atmosphere of 5% CO2. An aliquot was then diluted (1:1) with a solution of 0.4% Trypan blue stain.
After a few minutes at room temperature, cells were counted under an optical microscope in a Thoma
hemocytometer chamber by two different operators. The values are expressed as % of viable cells.
The cell viability in control samples was always 97–98%.
4.6. LDH Assay
The cytotoxic effects of 0.2 and 2 µg/mL suspensions of p-SWCNTs and GO were measured in
the treated EaHy926, HEp-2, HUVEC and HeLa supernatants by quantitating the release of lactate
dehydrogenase (LDH) at different treatment times (6, 12, 24 and 48 h). Following incubation, an aliquot
(200 µL/well) of treated cells or untreated cells was centrifuged for 5 min at 4 ◦C and 13,000 rpm.
Supernatants were collected for the LDH measurements according to the manufacturer’s instructions
(Thermo scientific, Cambridge, MA, USA). The assay was performed in a 96-well plate, while the
absorbance was measured at 490 and 680 nm by using a UV-Vis spectrophotometer (Jenway, Genova,
Italy). LDH activity was obtained by subtracting the 680-nm value from the 490-nm absorbance.
The preliminary experiments were set in each cell line to determine the maximum LDH activity that
was necessary for the determination of the percentage of cytotoxicity according to this formula:
% cytotoxicity =
Treated cells LDH − Control cells LDH
Maximum LDH − Control cells LDH × 100 (1)
The maximum LDH activity was 1.2 (A 490–680 nm) in each cell line.
4.7. Statistics
All statistical analyses were carried out using Kaleida Graph version 4.5.1 (Synergy Software Inc.,
Reading, PA, USA). The data are expressed as means ± standard deviation. The differences between
the differently treated cell populations were analyzed using Student’s t test. p < 0.05 was considered to
indicate a statistically significant difference. The significant p values are reported in figure legends.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/19/5/
1316/s1.
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